Jorge Benetucci

Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial

Ulrik Bak Dragsted, Jan Gerstoft, Court Pedersen et al. · The Journal of Infectious Diseases · 2003 · 118 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

Michael J. Kozal, Sergio Lupo, Edwin DeJesus et al. · HIV Clinical Trials · 2012 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +17

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients

Gabriela de Larrañaga, Alejandro Petroni, Gabriel Deluchi et al. · Blood Coagulation & Fibrinolysis · 2003 · 73 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

A Randomized Trial to Evaluate Lopinavir/Ritonavir versus Saquinavir/Ritonavir in HIV-1-Infected Patients: The Maxcmin2 Trial

Waldo Belloso, Silvina Ivalo, Jorge Benetucci et al. · Antiviral Therapy · 2005 · 68 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4⁺Cell Counts ⩾350/mm³

Marcelo Losso, Waldo Belloso, Sean Emery et al. · The Journal of Infectious Diseases · 2000 · 67 citations

Life Sciences, Immunology, Infectious Diseases +13